Skip to content

Clinical Investigation of Refraction Techniques

Clinical Investigation of Refraction Techniques

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05461586
Enrollment
35
Registered
2022-07-18
Start date
2022-07-14
Completion date
2022-08-09
Last updated
2023-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Brief summary

Prospective, multi-center, non-interventional, randomized, comparative clinical study to identify an optimal refractive technique that provides maximum plus refractive endpoint for best corrected distance visual acuity (BCDVA).

Interventions

DEVICERefractive Technique (MR #1)

Fogging method that employs fogging lens to ensure there is sufficient visual defocus to induce blur.

DEVICERefractive Technique (MR #2)

Duochrome method that employs the chromatic aberration of the eye, with the shorter wavelengths (green) focused in front of the longer (red) wavelengths

Sponsors

Johnson & Johnson Surgical Vision, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Participant in PCOL-102-AHSF who were bilaterally implanted with TECNIS IOL, Models C1V000, C2V000 or ICB00 and have completed and are at least 30 days postoperative from their second eye surgery; 2. At least one implanted eye with clear ocular media; 3. Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in Australia and New Zealand; 4. Availability, willingness and sufficient cognitive awareness to comply with examination procedures.

Exclusion criteria

1. Best-corrected distance visual acuity (BCDVA) worse than 0.66 decimal (6/9 or 20/30 Snellen); 2. Subjects with ongoing adverse events that might impact outcomes during the study visit as determined by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
Difference between two manifest refractive techniques on outcome variable MRSEDay 0Refractive technique 1 will use a plus lens fogging technique and refractive technique 2 will use the Duochrome technique to achieve maximum plus refraction for best-corrected visual acuity (BCDVA).
Difference between two manifest refractive techniques on visual acuityDay 0Refractive technique 1 will use a plus lens fogging technique and refractive technique 2 will use the Duochrome technique to achieve maximum plus refraction for best-corrected visual acuity (BCDVA).

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026